INTERNATIONAL PATENT: BETAGENON AB FILES APPLICATION FOR "USE OF TRYPTOPHAN AND METABOLITES THEREOF AS BIOMARKERS FOR TREATMENT METHODS"

GENEVA, Dec. 15 -- BETAGENON AB (Thulegatan 1A903 26 Umea) filed a patent application (PCT/EP2025/065202) for "USE OF TRYPTOPHAN AND METABOLITES THEREOF AS BIOMARKERS FOR TREATMENT METHODS" on Jun 02, 2025. With publication no. WO/2025/252672, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): EDLUND, Helena (c/o Betagenon ABThulegatan 1A903 26 Umea), STENEBERG, Par (c/o Betagenon ABThulegatan 1A903 26 Umea), CHORELL, Elin (c/o Betagenon ABThulegatan 1A903 26 Umea)

Abstract: Provided herein is the use of certain biomarkers,...